Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
230.67 USD | -0.65% |
|
-3.76% | -9.08% |
11/07 | Deutsche Bank Lowers Price Target on Humana to $224 From $262, Keeps Hold Rating | MT |
10/07 | Marsh Mclennan Appoints Bruce Broussard to Its Board of Directors, Effective July 9, 2025 | CI |
Company Valuation: Humana Inc.
Data adjusted to current consolidation scope
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 54,296 | 59,622 | 64,843 | 56,361 | 30,550 | 27,840 | - | - |
Change | - | 9.81% | 8.76% | -13.08% | -45.8% | -8.87% | - | - |
Enterprise Value (EV) 1 | 56,283 | 68,722 | 70,908 | 63,323 | 40,050 | 35,412 | 34,124 | 33,605 |
Change | - | 22.1% | 3.18% | -10.7% | -36.75% | -11.58% | -3.64% | -1.52% |
P/E ratio | 16.2x | 20.5x | 23.2x | 22.9x | 25.4x | 15x | 17.7x | 11.2x |
PBR | 3.85x | 3.73x | 4.18x | 3.44x | 1.87x | 1.58x | 1.49x | 1.35x |
PEG | - | -2x | -8.91x | -2.43x | -0.5x | 0.3x | -1.2x | 0.2x |
Capitalization / Revenue | 0.7x | 0.72x | 0.7x | 0.53x | 0.26x | 0.22x | 0.21x | 0.2x |
EV / Revenue | 0.73x | 0.83x | 0.76x | 0.6x | 0.34x | 0.28x | 0.26x | 0.24x |
EV / EBITDA | 13.3x | 16.1x | 13.8x | 11.1x | 9.02x | 8.69x | 9.13x | 7.41x |
EV / EBIT | 15x | 27.6x | 16.1x | 12.7x | 11.3x | 10.6x | 11.5x | 8.48x |
EV / FCF | 12x | 72.6x | 20.5x | 21.3x | 16.8x | 12.1x | 13.5x | 10.5x |
FCF Yield | 8.31% | 1.38% | 4.89% | 4.7% | 5.97% | 8.25% | 7.41% | 9.53% |
Dividend per Share 2 | 2.5 | 2.725 | 3.15 | 3.54 | 3.54 | 3.677 | 3.897 | 4.038 |
Rate of return | 0.61% | 0.59% | 0.62% | 0.77% | 1.4% | 1.59% | 1.69% | 1.75% |
EPS 2 | 25.31 | 22.67 | 22.08 | 20 | 9.98 | 15.33 | 13.04 | 20.56 |
Distribution rate | 9.88% | 12% | 14.3% | 17.7% | 35.5% | 24% | 29.9% | 19.6% |
Net sales 1 | 77,155 | 83,064 | 92,870 | 1,06,374 | 1,17,761 | 1,26,619 | 1,30,320 | 1,40,744 |
EBITDA 1 | 4,240 | 4,278 | 5,122 | 5,711 | 4,442 | 4,077 | 3,736 | 4,537 |
EBIT 1 | 3,751 | 2,488 | 4,413 | 4,999 | 3,543 | 3,330 | 2,973 | 3,963 |
Net income 1 | 3,367 | 2,933 | 2,806 | 2,489 | 1,207 | 1,865 | 1,563 | 2,472 |
Net Debt 1 | 1,987 | 9,100 | 6,065 | 6,962 | 9,500 | 7,572 | 6,284 | 5,765 |
Reference price 2 | 410.27 | 463.86 | 512.19 | 457.81 | 253.71 | 230.67 | 230.67 | 230.67 |
Nbr of stocks (in thousands) | 1,32,341 | 1,28,534 | 1,26,600 | 1,23,111 | 1,20,411 | 1,20,693 | - | - |
Announcement Date | 03/02/21 | 02/02/22 | 01/02/23 | 25/01/24 | 11/02/25 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
---|---|---|---|---|---|---|
15.04x | 0.28x | 8.69x | 1.59% | 2.78TCr | ||
14.35x | 0.71x | 9.23x | 2.82% | 28TCr | ||
12.81x | 0.39x | 7.92x | 1.9% | 8.1TCr | ||
11.11x | 0.5x | 7.7x | 2.01% | 7.7TCr | ||
14.97x | 0.12x | 10.79x | 5.3% | 1.56TCr | ||
10.68x | 0.22x | 4.98x | -.--% | 1.2TCr | ||
-38.79x | 0.65x | 47.8x | -.--% | 264.52Cr | ||
42.47x | 1.39x | 8.6x | -.--% | 198.95Cr | ||
-23.48x | 0.69x | 22.87x | -.--% | 148.6Cr | ||
Average | 6.57x | 0.55x | 14.29x | 1.51% | 5.51TCr | |
Weighted average by Cap. | 13.28x | 0.57x | 8.94x | 2.45% |
Year-on-year evolution of the PER
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- HUM Stock
- Valuation Humana Inc.
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition